BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren H, Zhang Z, Zhang W, Feng X, Xu L. Prodrug-type antisense oligonucleotides with enhanced nuclease stability and anti-tumour effects. Eur J Pharm Sci 2021;162:105832. [PMID: 33826934 DOI: 10.1016/j.ejps.2021.105832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Arriaga-canon C, Contreras-espinosa L, Rebollar-vega R, Montiel-manríquez R, Cedro-tanda A, García-gordillo JA, Álvarez-gómez RM, Jiménez-trejo F, Castro-hernández C, Herrera LA. Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection. IJMS 2022;23:11058. [DOI: 10.3390/ijms231911058] [Reference Citation Analysis]
2 Zhang Z, Ren H, Chen Z, Zhang Y, Zhang Z, Luo Y, Wang S, Feng X, Xu L. Dumbbell-Shaped Antisense Oligonucleotide Prodrugs Showed Improved Antinuclease Stability and Anticancer Efficacy. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.2c00396] [Reference Citation Analysis]
3 Li W, Gong H, Fu Y, Sun J, Wang Y. Novel pH-sensitive nanoparticles based on prodrug strategy to delivery All-Trans Retinoic Acid for breast cancer. Colloids Surf B Biointerfaces 2022;219:112838. [PMID: 36148708 DOI: 10.1016/j.colsurfb.2022.112838] [Reference Citation Analysis]